Skip to main content

Table 3 Univariate and multivariate analysis for OS in gastric cancer patients

From: The prognostic value of preoperative fibrinogen-to-prealbumin ratio and a novel FFC score in patients with resectable gastric cancer

Variables

Univariate analysis

Multivariate analysis

HR (95%CI)

P value

HR (95%CI)

P value

Gender

0.742 (0.505–1.091)

0.129

  

Age

1.270 (0.916–1.761)

0.152

  

Pathological differention

1.191 (0.909–1.562)

0.205

  

Lymph nodes metastasis

5.119 (3.296–7.952)

< 0.001

1.646 (0.864–3.135)

0.130

TNM stage

3.147 (2.385–4.151)

< 0.001

3.564 (1.321–9.618)

0.012

Borrmann type

1.433 (1.238–1.658)

< 0.001

0.980 (0.808–1.187)

0.834

Tumor size

3.587 (2.559–5.028)

< 0.001

1.958 (1.349–2.842)

< 0.001

Body mass index

0.884 (0.619–1.264)

0.500

  

Anemia status

1.512 (1.071–2.134)

0.019

0.971 (0.676–1.394)

0.872

CEA

1.686 (1.155–2.462)

0.007

1.422 (0.959–2.107)

0.080

CA199

1.648 (1.106–2.455)

0.014

1.043 (0.689–1.579)

0.842

FPR

2.499 (1.794–3.483)

< 0.001

1.595 (1.072–2.373)

0.021

FAR

2.343 (1.673–3.280)

< 0.001

1.236 (0.829–1.842)

0.299

FFC score

1.704 (1.446–2.009)

< 0.001

1.414 (1.189–1.683)

< 0.001

  1. OS overall survival; HR hazard ratio; CI confidence interval; CEA carcinoembryonic antigen; CA199 carbohydrate antigen 199; FPR fibrinogen-to-prealbumin ratio; FAR fibrinogen-to-albumin ratio; FFC FPR-FAR-CEA